Fungal Species: Not specified

A systematic review to assess the use of psilocybin in the treatment of headaches

mycolabadmin

Researchers reviewed eight studies examining whether psilocybin, a naturally occurring psychedelic compound found in certain mushrooms, could treat various types of headaches and migraines. Most studies found that psilocybin provided clinically significant relief, with participants experiencing improvements in how often they got headaches, how intense they were, and how long they lasted. However, some users experienced side effects like hallucinations or temporary increases in anxiety, and the compound remains illegal in most countries, limiting current research.

Read More »

Psilocybin-induced changes in neural reactivity to alcohol and emotional cues in patients with alcohol use disorder: An fMRI pilot study

mycolabadmin

This pilot study examined how psilocybin affects the brains of people with alcohol use disorder. Using brain imaging (fMRI), researchers found that psilocybin increased activity in brain regions associated with decision-making and emotional control while decreasing activity in regions linked to cravings. These findings suggest psilocybin may help people with alcohol addiction by enhancing their ability to regulate emotions and resist urges to drink.

Read More »

Psilocybin Does Not Induce Conditioned Place Preference, But Modifies Behavioral Patterns in Sprague-Dawley Rats

mycolabadmin

Researchers tested whether psilocybin, a compound found in magic mushrooms, could be addictive by examining reward-seeking behavior in rats. The study found that psilocybin did not create rewarding effects that would typically lead to addiction, and only temporarily changed specific behaviors like head-twitching and grooming while the drug was active. These findings suggest that psilocybin has a low addiction potential and may be safe for therapeutic use in treating mental health conditions.

Read More »

Investigating the Potential of Psilocybin for Compulsive Eating in a Rat Model of Binge Eating

mycolabadmin

Researchers tested whether psilocybin, a psychedelic compound from magic mushrooms, could help reduce compulsive eating in rats bred to binge eat high-fat, high-sugar foods. Using a fear-conditioning experiment, they found that a single dose of psilocybin did not reduce the rats’ compulsive eating behavior at the dosage tested. However, the treatment may have affected fear-related freezing responses, suggesting psilocybin might influence brain circuits involved in learning and memory.

Read More »

New epidemiological routes of Coccidioidomycosis in Mexico – the extension of this pathogen to new areas

mycolabadmin

Coccidioidomycosis, a fungal lung disease traditionally found in desert regions of Mexico and the southwestern United States, is spreading to new areas where it was never seen before. Researchers tracked 122 cases between 1991 and 2023 and found that nearly half of the patients had no history of travel to known high-risk areas, suggesting the disease is becoming established in new locations. Climate change and drought conditions are likely helping the fungus expand its range, making it important for doctors everywhere to consider this disease when diagnosing respiratory infections.

Read More »

Deep learning application to hyphae and spores identification in fungal fluorescence images

mycolabadmin

Researchers developed an artificial intelligence system that can automatically identify fungal infections in microscope images as accurately as experienced doctors. The system uses two different AI models working together to spot fungal spores, thread-like hyphae, and mycelium in fluorescence images. This technology could significantly reduce the time doctors spend analyzing samples and help ensure more accurate diagnoses, especially in hospitals with fewer experienced specialists.

Read More »
Scroll to Top